Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Michael G Sugiyama"'
Autor:
Timothy J Walker, Eduardo Reyes-Alvarez, Brandy D Hyndman, Michael G Sugiyama, Larissa CB Oliveira, Aisha N Rekab, Mathieu JF Crupi, Rebecca Cabral-Dias, Qianjin Guo, Patricia LM Dahia, Douglas S Richardson, Costin N Antonescu, Lois M Mulligan
Publikováno v:
eLife, Vol 12 (2024)
Internalization from the cell membrane and endosomal trafficking of receptor tyrosine kinases (RTKs) are important regulators of signaling in normal cells that can frequently be disrupted in cancer. The adrenal tumor pheochromocytoma (PCC) can be cau
Externí odkaz:
https://doaj.org/article/56671c5952a34e068944e75893122071
Autor:
Dana Praslickova, Enrique C Torchia, Michael G Sugiyama, Elijah J Magrane, Brittnee L Zwicker, Lev Kolodzieyski, Luis B Agellon
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e50810 (2012)
The ileal lipid binding protein (ilbp) is a cytoplasmic protein that binds bile acids with high affinity. However evidence demonstrating the role of this protein in bile acid transport and homeostasis is missing. We created a mouse strain lacking ilb
Externí odkaz:
https://doaj.org/article/a8e76d246a484f5ab6471b2854d4f9b2
Autor:
Michael G. Sugiyama, Aidan I. Brown, Jesus Vega-Lugo, Jazlyn P. Borges, Andrew M. Scott, Khuloud Jaqaman, Gregory D. Fairn, Costin N. Antonescu
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract The epidermal growth factor receptor (EGFR) is a central regulator of cell physiology. EGFR is activated by ligand binding, triggering receptor dimerization, activation of kinase activity, and intracellular signaling. EGFR is transiently con
Externí odkaz:
https://doaj.org/article/a76bca4ec1bb40f1bbe42379e8c8888d
The epidermal growth factor receptor (EGFR) is a central regulator of cell physiology that is stimulated by multiple distinct ligands. Although ligands bind to EGFR while the receptor is exposed on the plasma membrane, EGFR incorporation into endosom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6dd4e041061d47d780fb2239428ebab3
https://doi.org/10.1101/2023.05.09.539827
https://doi.org/10.1101/2023.05.09.539827
Autor:
Costin N. Antonescu, Bo Wang, Stephen S. MacKinnon, Vijay Shahani, Jean-Philippe Julien, Andreas Windemuth, Seyed Ali Madani Tonekaboni, Gregory D. Fairn, Sarah A. Sabatinos, Raffi Karshafian, Roberto Botelho, Andrew Haller, Russell D. Viirre, Joseph B. McPhee, Rahul Misra, Kyle Cheung, Sikander Hayat, Hassaan Maan, Edurne Rujas, Mehran Karimzadeh, Dar’ya S. Redka, Haotian Cui, Michael G. Sugiyama
The COVID-19 pandemic has highlighted the urgent need for the identification of new antiviral drug therapies for a variety of diseases. COVID-19 is caused by infection with the human coronavirus SARS-CoV-2, while other related human coronaviruses cau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40a129474d5f09baee846b06163aa1f9
https://doi.org/10.32920/21982913.v1
https://doi.org/10.32920/21982913.v1
Autor:
Michael G. Sugiyama, Aidan I. Brown, Jesus Vega-Lugo, Andrew M. Scott, Khuloud Jaqaman, Gregory D. Fairn, Costin N. Antonescu
The epidermal growth factor receptor (EGFR) is a central regulator of cell physiology. EGFR is activated by ligand binding, triggering receptor dimerization, activation of kinase activity, and intracellular signaling. EGFR is transiently confined wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8a4c28baec0cf507dbb66aed378eb83
https://doi.org/10.1101/2022.03.04.483015
https://doi.org/10.1101/2022.03.04.483015
Autor:
Peter King, Clare E. Futter, Costin N. Antonescu, Mikkel W. Pedersen, Daniel Hochhauser, John A. Hartley, Michael Kragh, Sylwia Jones, Nicos Angelopoulos, Michael G. Sugiyama, Amandeep Bhamra, Silvia Surinova
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-19 (2020)
Scientific Reports
Scientific Reports
Antibody combinations targeting cell surface receptors are a new modality of cancer therapy. The trafficking and signalling mechanisms regulated by such therapeutics are not fully understood but could underlie differential tumour responses. We explor
Autor:
Warren L. Lee, Heino Velazquez, George Tellides, Martin A. Schwartz, Chirosree Bandyopadhyay, Michael G. Sugiyama, Carlos Fernández-Hernando, Jan R. Kraehling, Miguel A. Lasunción, Victoria Ulrich, William C. Sessa, Shun He, Cristina M. Ramírez, Chin Sheng Lin, Guangxin Li, Yajaira Suárez, Noemi Rotllan, Xinran Liu, Xinbo Zhang, Filip K. Swirski, Binod Aryal
Publikováno v:
Circulation. 140:225-239
Background: Atherosclerosis is driven by synergistic interactions between pathological, biomechanical, inflammatory, and lipid metabolic factors. Our previous studies demonstrated that absence of caveolin-1 (Cav1)/caveolae in hyperlipidemic mice stro
Autor:
Edurne Rujas, Andrew Haller, Joseph B. McPhee, Roberto J. Botelho, Sarah A. Sabatinos, Mehran Karimzadeh, Bo Wang, Vijay M. Shahani, Seyed Ali Madani Tonekaboni, Andreas Windemuth, Raffi Karshafian, Gregory D. Fairn, Sikander Hayat, Haotian Cui, Hassaan Maan, Michael G. Sugiyama, Stephen S. MacKinnon, Costin N. Antonescu, Rahul Misra, Russell D. Viirre, Kyle Cheung, Dar’ya S. Redka, Jean-Philippe Julien
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-18 (2021)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Scientific Reports, Vol 11, Iss 1, Pp 1-18 (2021)
Digital.CSIC. Repositorio Institucional del CSIC
instname
The COVID-19 pandemic has highlighted the urgent need for the identification of new antiviral drug therapies for a variety of diseases. COVID-19 is caused by infection with the human coronavirus SARS-CoV-2, while other related human coronaviruses cau
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 38:2283-2294
Objective— The atheroprotective effects of estrogen are independent of circulating lipid levels. Whether estrogen regulates transcytosis of LDL (low-density lipoprotein) across the coronary endothelium is unknown. Approach and Results— Using tota